The authors of “Prohibition of Gender-Affirming Care as a Form of Child Maltreatment: Reframing the Discussion”1  state that GAC “does not cause harm” and “decreases many negative health outcomes, including rates of depression.” No relevant citations are provided for this claim. Although youth GAC has the support of the professional medical community in the United States,2 4  that does not mean there is no risk of harm. Infertility, lack of development of genital tissue, problems with sexual functioning, psychosocial/cognitive delay, decrease in bone mineral density accrual, and the known side effect profiles of estrogen and testosterone (eg, thrombotic events, cardiovascular disease, etc) are all potential risks associated with the hormonal agents used in youth GAC.5  Furthermore, systematic reviews6 9  have found the quality of evidence in this field is low, meaning the literature does not actually show, with any reasonable degree of certainty, that youth GAC decreases rates of negative mental health outcomes. This runs contrary to the authors’ claim that use of hormonal interventions in this population is “supported by a wealth of research on their safety and effectiveness.” Later in the paper, the authors reiterate that “GAC…entirely mitigates the increased risk of depression and suicidal ideation.” The citation for this claim is Tordoff et al 2022,10  which is the only clinical research study involving youth GAC in the reference list. This was an observational study of hormonal treatment in which there was no significant change in mental health outcomes over time. Some participants did not start hormones and had high rates of depression/suicidal ideation at the end of the study period; however, this was a tiny number (n = 7), and any resulting statistical comparison cannot support the assertion that depression and suicidal ideation were “entirely mitigated” in this study.10 

In fact, there are multiple clinical research studies looking at hormonal treatment in TGD youth in which depression outcome measures did not significantly improve over time.11 14  In the largest such study, the depression outcome measure actually significantly worsened after initiation of hormonal treatment.15  It is also worth noting that suicidality research in this field is decidedly mixed. For example, in a recently-published study, n = 2 participants taking hormonal treatment completed suicide during the study period.16 

It is important for the health and well-being of children and adolescents in the United States that loving and supportive parents not be unjustly criminalized. However, this perspectives paper paints a complex and controversial issue as simplistic, and depicts circumspect approaches to care (ie, any type of management that does not involve using hormonal interventions in TGD adolescents) as “abuse.” If this is the case, should doctors and parents who favor conservative management (as is increasingly the standard of care in European countries, some of which have changed guidelines after the publication of the above-mentioned systematic reviews) be considered “abusers” due to concerns about risks and a tepid evidence base? Ultimately, it is not helpful to patients, parents, or pediatricians for evidence to be misrepresented, for opinion to be stated as fact, or for the complexities of youth GAC to be ignored in favor of portraying the issue as an uncomplicated one.

CONFLICT OF INTEREST DISCLOSURES: None declared.

1
Georges
E
,
Brown
ECB
,
Cohen
RS
.
Prohibition of gender-affirming care as a form of child maltreatment: reframing the discussion
.
Pediatrics
.
2024
;
153
(
1
):
e2023064292
2
Hembree
WC
,
Cohen-Kettenis
PT
,
Gooren
L
, et al
.
Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline
.
J Clin Endocrinol Metab
.
2017
;
102
(
11
):
3869
3903
3
Rafferty
J
;
COMMITTEE ON PSYCHOSOCIAL ASPECTS OF CHILD AND FAMILY HEALTH
;
COMMITTEE ON ADOLESCENCE
;
SECTION ON LESBIAN, GAY, BISEXUAL, AND TRANSGENDER HEALTH AND WELLNESS
.
Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents
.
Pediatrics
.
2018
;
142
(
4
):
e20182162
4
Coleman
E
,
Radix
AE
,
Bouman
WP
, et al
.
Standards of care for the health of transgender and gender diverse people, version 8
.
Int J Transgend Health
.
2022
;
23
(
Suppl 1
):
S1
S259
5
Clayton
A
.
Gender-affirming treatment of gender dysphoria in youth: A perfect storm environment for the placebo effect-the implications for research and clinical practice
. [published correction appears in Arch Sex Behav. 2022 Dec 13]
Arch Sex Behav
.
2023
;
52
(
2
):
483
494
6
National Institute for Health and Care Excellence
.
Evidence Review: Gonadotropin releasing hormone analogues for children and adolescents with gender dysphoria [NICE Evidence Review]
. Published
2020
.
7
National Institute for Health and Care Excellence
.
Evidence Review: Gender-affirming hormones for children and adolescents with gender dysphoria [NICE Evidence Review]
. Published
2020
.
8
Ludvigsson
JF
,
Adolfsson
J
,
Höistad
M
,
Rydelius
PA
,
Kriström
B
,
Landén
M
.
A systematic review of hormone treatment for children with gender dysphoria and recommendations for research
.
Acta Paediatr
.
2023
;
112
(
11
):
2279
2292
9
Thompson
L
,
Sarovic
D
,
Wilson
P
, et al
.
A PRISMA systematic review of adolescent gender dysphoria literature: 3) treatment
.
PLOS Glob Public Health
.
2023
;
3
(
8
):
e0001478
10
Tordoff
DM
,
Wanta
JW
,
Collin
A
,
Stepney
C
,
Inwards-Breland
DJ
,
Ahrens
K
.
Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care
.
JAMA Netw Open
.
2022
;
5
(
2
):
e220978
11
de Vries
ALC
,
McGuire
JK
,
Steensma
TD
,
Wagenaar
EC
,
Doreleijers
TA
,
Cohen-Kettenis
PT
.
Young adult psychological outcome after puberty suppression and gender reassignment
.
Pediatrics
.
2014
;
134
(
4
):
696
704
12
Cantu
AL
,
Moyer
DN
,
Connelly
KJ
,
Holley
AL
.
Changes in anxiety and depression from intake to first follow-up among transgender youth in a pediatric endocrinology clinic
.
Transgend Health
.
2020
;
5
(
3
):
196
200
13
Carmichael
P
,
Butler
G
,
Masic
U
, et al
.
Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK
.
PLoS One
.
2021
;
16
(
2
):
e0243894
14
Becker-Hebly
I
,
Fahrenkrug
S
,
Campion
F
,
Richter-Appelt
H
,
Schulte-Markwort
M
,
Barkmann
C
.
Psychosocial health in adolescents and young adults with gender dysphoria before and after gender-affirming medical interventions: a descriptive study from the Hamburg Gender Identity Service
.
Eur Child Adolesc Psychiatry
.
2021
;
30
(
11
):
1755
1767
15
Hisle-Gorman
E
,
Schvey
NA
,
Adirim
TA
, et al
.
Mental healthcare utilization of transgender youth before and after affirming treatment
.
J Sex Med
.
2021
;
18
(
8
):
1444
1454
16
Chen
D
,
Berona
J
,
Chan
Y-M
, et al
.
Psychosocial functioning in transgender youth after 2 years of hormones
.
N Engl J Med
.
2023
;
388
(
3
):
240
250